Immunisation with bacterial expressed VP2 and VP5 of bluetongue virus (BTV) protect α/β interferon-receptor knock-out (IFNAR-/-) mice from homologous lethal challenge

Vaccine

Volumn 32, Issue 32, 2014, Pages 4059-4067

  Mohd Jaafar, Fauziah ^a   Belhouchet, Mourad ^a   Vitour, Damien ^b   Adam, Micheline ^b   Breard, Emmanuel ^b   Zientara, Stéphan ^b   Mertens, Peter P C ^a   Attoui, Houssam ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Bluetongue virus; Capsid subunit vaccine; Neutralising antibodies; Orbivirus

Indexed keywords

GLUTATHIONE TRANSFERASE; NEUTRALIZING ANTIBODY; PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VP5 PROTEIN; ALPHA BETA INTERFERON RECEPTOR; CAPSID PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE; VP2 PROTEIN, BLUETONGUE VIRUS; VP5 PROTEIN, BLUETONGUE VIRUS;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLUETONGUE ORBIVIRUS; CONTROLLED STUDY; FEMALE; HEMODILUTION; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BLUETONGUE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; CAPSID PROTEINS; FEMALE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; VIRAL VACCINES;

EID: 84902546588     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.056     Document Type: Article

References (63)

1. Mertens P.P.C., Attoui H., Duncan R., Dermody T.S. Reoviridae. Virus taxonomy eighth report of the international committee on taxonomy of viruses 2005, 447-454. Elsevier/Academic Press, London. C. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
2. Attoui H., Mertens P.P.C., Becnel J., Belaganahalli M., Bergoin M., Brussaard C.P., et al. The double stranded RNA viruses. Virus taxonomy: ninth report of the international committee on taxonomy of viruses 2011, 497-637. Academic Press, London. A.M.Q. King, E.B. Carstens, E.J. Lefkowitz (Eds.).
3. Erasmus B.J. Bluetongue in sheep and goats. Aust Vet J 1975, 51:165-170.
4. Darpel K.E., Batten C.A., Veronesi E., Shaw A.E., Anthony S., Bachanek-Bankowska K., et al. Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet Rec 2007, 161:253-261.
5. Purse B.V., Mellor P.S., Rogers D.J., Samuel A.R., Mertens P.P., Baylis M. Climate change and the recent emergence of bluetongue in Europe. Nat Rev Microbiol 2005, 3:171-181.
6. Mertens P.P., Maan N.S., Prasad G., Samuel A.R., Shaw A.E., Potgieter A.C., et al. Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains. J Gen Virol 2007, 88:2811-2823.
7. Hofmann M.A., Renzullo S., Mader M., Chaignat V., Worwa G., Thuer B. Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg Infect Dis 2008, 14:1855-1861.
8. Maan S., Maan N.S., Ross-smith N., Batten C.A., Shaw A.E., Anthony S.J., et al. Sequence analysis of bluetongue virus serotype 8 from the Netherlands 2006 and comparison to other European strains. Virology 2008, 377:308-318.
9. Wouda W., Roumen M.P., Peperkamp N.H., Vos J.H., van Garderen E., Muskens J. Hydranencephaly in calves following the bluetongue serotype 8 epidemic in the Netherlands. Vet Rec 2008, 162:422-423.
10. Hoogendam K. International study on the economic consequences of outbreaks of bluetongue serotype 8 in north-western Europe 2007, University of Van Hall-Larenstein, Leeuwarden.
11. Wilson A.J., Mellor P.S. Bluetongue in Europe: vectors, epidemiology and climate change. Proceedings of the conference 'Vector-Borne Diseases: Impact of Climate Change on Vectors and Rodent Reservoirs' 2007, H. Mehlhorn, B. Chobotar (Eds.).
12. Wilson A., Carpenter S., Gloster J., Mellor P. Re-emergence of bluetongue in northern Europe in 2007. Vet Rec 2007, 161:487-489.
13. Menzies F.D., McCullough S.J., McKeown I.M., Forster J.L., Jess S., Batten C., et al. Evidence for transplacental and contact transmission of bluetongue virus in cattle. Vet Rec 2008, 163:203-209.
14. Mertens P.P., Burroughs J.N., Anderson J. Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4. Virology 1987, 157:375-386.
15. Cowley J.A., Gorman B.M. Genetic reassortants for identification of the genome segment coding for the bluetongue virus hemagglutinin. J Virol 1987, 61:2304-2306.
16. van der Walt N.T. A haemagglutination and haemagglutination inhibition test for bluetongue virus. Onderstepoort J Vet Res 1980, 47:113-117.
17. Hassan S.S., Roy P. Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J Virol 1999, 73:9832-9842.
18. Mohd Jaafar F., Belhouchet M., Belaganahalli M., Tesh R.B., Mertens P.P.C., Attoui H. Full-genome characterisation of Orungo, Lebombo and Changuinola viruses provides evidence for co-evolution of orbiviruses with their arthropod vectors. PLoS ONE 2014, 9:e86392.
19. Belhouchet M., Mohd Jaafar F., Tesh R., Grimes J., Maan S., Mertens P.P., et al. Complete sequence of Great Island virus and comparison with the T2 and outer-capsid proteins of Kemerovo, Lipovnik and Tribec viruses (genus Orbivirus, family Reoviridae). J Gen Virol 2010, 91:2985-2993.
20. Attoui H., Maan S.S., Anthony S.J., Mertens P.P.C. Bluetongue virus, other orbiviruses and other reoviruses: their relationships and taxonomy. Bluetongue 2009, 23-52. Elsevier/Academic Press, London. P.S. Mellor, M. Baylis, P.P.C. Mertens (Eds.).
21. Umeshappa C.S., Singh K.P., Pandey A.B., Singh R.P., Nanjundappa R.H. Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep. Vaccine 2010, 28:2522-2531.
22. Belhouchet M., Mohd Jaafar F., Firth A.E., Grimes J.M., Mertens P.P., Attoui H. Detection of a fourth orbivirus non-structural protein. PLoS ONE 2011, 6:e25697.
23. Ratinier M., Caporale M., Golder M., Franzoni G., Allan K., Nunes S.F., et al. Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathogens 2011, 7:e1002477.
24. Maan S., Maan N.S., Samuel A.R., Rao S., Attoui H., Mertens P.P. Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes. J Gen Virol 2007, 88:621-630.
25. Maan S., Maan N.S., Nomikou K., Veronesi E., Bachanek-Bankowska K., Belaganahalli M.N., et al. Complete genome characterisation of a novel 26th bluetongue virus serotype from Kuwait. PLoS ONE 2011, 6:e26147.
26. Maan S., Maan N.S., Nomikou K., Batten C., Antony F., Belaganahalli M.N., et al. Novel bluetongue virus serotype from Kuwait. Emerg Infect Dis 2011, 17:886-889.
27. Hassan S.H., Wirblich C., Forzan M., Roy P. Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol 2001, 75:8356-8367.
28. Miroux B., Walker J.E. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 1996, 260:289-298.
29. Mohd Jaafar F., Attoui H., Gallian P., Isahak I., Wong K.T., Cheong S.K., et al. Recombinant VP9-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Banna virus (genus Seadornavirus). J Virol Methods 2004, 116:55-61.
30. Mohd Jaafar F., Attoui H., Gallian P., Biagini P., Cantaloube J.F., de Micco P., et al. Recombinant VP7-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Colorado tick fever virus. J Clin Microbiol 2003, 41:2102-2105.
31. Calvo-Pinilla E., Rodriguez-Calvo T., Anguita J., Sevilla N., Ortego J. Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS ONE 2009, 4:e5171.
32. Mohd Jaafar F., Attoui H., De Micco P., De Lamballerie X. Recombinant VP6-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Eyach virus (genus Coltivirus). J Clin Virol: Off Publ Pan American Soc Clin Virol 2004, 30:248-253.
33. Buckley A., Dawson A., Moss S.R., Hinsley S.A., Bellamy P.E., Gould E.A. Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J Gen Virol 2003, 84:2807-2817.
34. Attoui H., Billoir F., Cantaloube J.F., Biagini P., de Micco P., de Lamballerie X. Strategies for the sequence determination of viral dsRNA genomes. J Virol Methods 2000, 89:147-158.
35. Lv X., Mohd Jaafar F., Sun X., Belhouchet M., Fu S., Zhang S., et al. Isolates of Liao ning virus from wild-caught mosquitoes in the Xinjiang province of China in 2005. PLoS ONE 2012, 7:e37732.
36. Attoui H., Mohd Jaafar F., Belhouchet M., Tao S., Chen B., Liang G., et al. Liao ning virus, a new Chinese seadornavirus that replicates in transformed and embryonic mammalian cells. J Gen Virol 2006, 87:199-208.
37. Shaw A.E., Monaghan P., Alpar H.O., Anthony S., Darpel K.E., Batten C.A., et al. Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1. J Virol Methods 2007, 145:115-126.
38. Cowley J.A., Gorman B.M. Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21. Vet Microbiol 1989, 19:37-51.
39. Mertens P.P., Pedley S., Cowley J., Burroughs J.N., Corteyn A.H., Jeggo M.H., et al. Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. Virology 1989, 170:561-565.
40. Mertens P.P., Pedley S., Cowley J., Burroughs J.N. A comparison of six different bluetongue virus isolates by cross-hybridization of the dsRNA genome segments. Virology 1987, 161:438-447.
41. Moulin V., Noordegraaf C.V., Makoschey B., van der Sluijs M., Veronesi E., Darpel K., et al. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine. Vaccine 2012, 30:2228-2235.
42. Zientara S., MacLachlan N.J., Calistri P., Sanchez-Vizcaino J.M., Savini G. Bluetongue vaccination in Europe. Expert Rev Vaccines 2010, 9:989-991.
43. Roy P., Urakawa T., Van Dijk A.A., Erasmus B.J. Recombinant virus vaccine for bluetongue disease in sheep. J Virol 1990, 64:1998-2003.
44. Stewart M., Dovas C.I., Chatzinasiou E., Athmaram T.N., Papanastassopoulou M., Papadopoulos O., et al. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. Vaccine 2012, 30:2131-2139.
45. Anderson J., Hagglund S., Breard E., Comtet L., Lovgren Bengtsson K., Pringle J., et al. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle. Clin Vaccine Immunol 2013, 20:1115-1122.
46. Anderson J., Bréard E., Bengtsson K.L., Grönvik K.-O., Zientara S., Valarcher J.-F., et al. Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals. Clin Vaccine Immunol 2014, 21:443-452.
47. Jabbar T.K., Calvo-Pinilla E., Mateos F., Gubbins S., Bin-Tarif A., Bachanek-Bankowska K., et al. Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2. PLoS ONE 2013, 8:e60574.
48. de la Poza F., Calvo-Pinilla E., Lopez-Gil E., Marin-Lopez A., Mateos F., Castillo-Olivares J., et al. Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus. PLoS ONE 2013, 8:e70197.
49. Calvo-Pinilla E., Rodriguez-Calvo T., Sevilla N., Ortego J. Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection. Vaccine 2009, 28:437-445.
50. Franceschi V., Capocefalo A., Calvo-Pinilla E., Redaelli M., Mucignat-Caretta C., Mertens P., et al. Immunization of knock-out alpha/beta interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen. Vaccine 2011, 29:3074-3082.
51. Wade-Evans A.M., Romero C.H., Mellor P., Takamatsu H., Anderson J., Thevasagayam J., et al. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 1996, 220:227-231.
52. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 2007, 25:672-678.
53. Ma G., Eschbaumer M., Said A., Hoffmann B., Beer M., Osterrieder N. An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model. PLoS ONE 2012, 7:e34425.
54. Top S., Foucras G., Deplanche M., Rives G., Calvalido J., Comtet L., et al. Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus. Vaccine 2012, 30:1609-1616.
55. Alpar H.O., Bramwell V.W., veronesi E., Darpel K.E., Pastoret P.P., Mertens P.P.C. Bluetongue virus vaccines past and present. Bluetongue 2009, 397-428. Elsevier/Academic Press, London. P.S. Mellor, M. Baylis, P.P.C. Mertens (Eds.).
56. DeMaula C.D., Heidner H.W., Rossitto P.V., Pierce C.M., MacLachlan N.J. Neutralization determinants of United States bluetongue virus serotype ten. Virology 1993, 195:292-296.
57. Wei P., Sun E.C., Liu N.H., Yang T., Xu Q.Y., Zhao J., et al. Identification of a novel bluetongue virus 1-specific B-cell epitope using a monoclonal antibody against the VP2 protein. Arch Virol 2013, 158:1099-1104.
58. Wang W.S., Sun E.C., Xu Q.Y., Yang T., Qin Y.L., Zhao J., et al. Identification of two novel BTV16-specific B cell epitopes using monoclonal antibodies against the VP2 protein. Appl Microbiol Biotechnol 2013, 97:5933-5942.
59. Hwang G.Y., Li J.K. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13. Virology 1993, 195:859-862.
60. Grimes J.M., Burroughs J.N., Gouet P., Diprose J.M., Malby R., Zientara S., et al. The atomic structure of the bluetongue virus core. Nature 1998, 395:470-478.
61. Wade-Evans A.M., Pullen L., Hamblin C., O'Hara R., Burroughs J.N., Mertens P.P. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge. J Gen Virol 1997, 78(Pt 7):1611-1616.
62. Hutchinson I.R. The role of VP7 (T13) in initiation of infection by bluetongue virus 1999, University of Hertfordshire.
63. Jeggo M.H., Wardley R.C. Bluetongue vaccine: cells and/or antibodies. Vaccine 1985, 3:57-58.